Home > Insider Trading > Filing (0001144204-14-058332)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1571865	W. Timothy Trost	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713	Sr. Vice President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-25	5,000	$2.35	8,839	No	4	M	Direct
Common Stock	Disposition	2014-09-25	5,000	$27.75	3,839	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-25	5,000	$0.00	5,000	$2.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
109,014		2021-04-06	No	4	M	Direct

Footnotes

The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2013.
Includes 657 shares of Common Stock that were acquired by the Reporting Person on September 10, 2014 pursuant to the Issuer's Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.85 to $28.31 inclusive. The reporting person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after July 26, 2010; the remainder of the shares vest in equal monthly installments thereafter over the next three years.